GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
902
c/glp1science·posted 1 months ago by u/lurker_for_years

someone explain receptor to me like I have not read a paper in years

Question Clean Column ×7 Cold Box ×3

Long-ish post, sorry. tl;dr at the bottom.

I have been tracking mechanism against triglycerides for 7 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here.

Caveats up front: one person, one lab, one assay, no control, and I changed my training in the middle of it, which was stupid.

tl;dr: probably real, definitely smaller than the threads imply, and not worth reorganising your week around.

995 up / 93 down91% upvoted25 commentsid 1vsd1i13 Jun 2026

25 comments

8 in this archive, depth 3

best — the order this archive was captured in

u/santiago_rasmussen82 points·1 months ago

the 3-day half-life means week 3 is still ramp-up pharmacokinetically

replysharereportpermalink
u/trialwatch_theoMOD62 points·1 months ago

Tracking number removed. It identifies both ends of a shipment.

replysharereportpermalink
u/lurker_for_yearsOP-11 points·1 months ago

Stomach physiology changed when I moved up to 2.5mg. Gastric emptying lag is the whole story.

replysharereportpermalink
u/neha_krastev49 points·1 months ago

Which paper are you quoting?

replysharereportpermalink
u/incretin_ivypharmacology20 points·1 months ago

the half-life is appetite, affects steady state timing

replysharereportpermalink
u/ireland_drugs_pay31 points·1 months ago

do not extrapolate rodent data to human dosing without saying so

replysharereportpermalink
u/flair_enthusiast23 points·1 months ago

This is correct. Rodent data is investigational, not predictive.

replysharereportpermalink
[removed]15 points·1 months ago

[removed by moderator]

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/glp1science
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/incretin_ivyu/trialwatch_theou/gastric_emptying_gu/sig_figs_sam
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →